Autopsy report · NCT02768337

Cambridge Brain Mets Trial 1

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 2 months after it had already started.
Ran for about 6 years 5 months before it stopped.
26 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Sponsor type: University, hospital or other
Conditions: Lung Cancer; Breast Cancer; Brain Cancer; Advanced Breast Cancer; Advanced Lung Cancer
Interventions: Afatinib; 2 Gy targeted radiotherapy; 4 Gy targeted radiotherapy
Participants: 26
Sites: 6
Countries: United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.